07:00 , Oct 22, 2007 |  BC Week In Review  |  Company News

Meldex drug delivery news

MDX (formerly BioProgress plc ) formed its Dexo Germany subsidiary to market and distribute the company's products in Germany. Dexo plans to launch an undisclosed analgesic product incorporating MDX's TabWrap drug delivery product by year...
08:00 , Feb 12, 2007 |  BC Week In Review  |  Company News

BioProgress, Uluru deal

BPRG received exclusive rights to market ULUR's OraDisc B benzocaine to treat oral pain in Europe, the Commonwealth of Independent States and the Middle East. The product uses ULUR's OraDisc polymer film drug delivery technology....
08:00 , Jan 1, 2007 |  BC Week In Review  |  Company News

BioProgress, Inyx sales and marketing update

BPRG granted IYXI's subsidiary Inyx Pharma Ltd. co-commercialization rights to TABWRAP, a process for wrapping tablets or caplets in an ingestible film. Financial terms were not disclosed. BioProgress plc (LSE:BPRG; BPRG), Cambridge, U.K.   Inyx...
08:00 , Dec 18, 2006 |  BC Week In Review  |  Company News

BioProgress, Uluru deal

BPRG and ULUR partnered to develop a treatment for aphthous ulcers using ULUR's OraDisc polymer film drug delivery technology. BPRG will market the product in Europe, the Commonwealth of Independent States (CIS) and Middle Eastern...
08:00 , Dec 4, 2006 |  BC Week In Review  |  Company News

BioProgress, FMC Corp. deal

BPRG agreed to restructure a 2003 deal under which FMC received an exclusive worldwide license to BPRG's NRobe oral drug delivery technology (see BioCentury, Oct. 27, 2003). BPRG is now eligible for 20% of milestone...
08:00 , Nov 6, 2006 |  BC Week In Review  |  Company News

BioProgress, airPharma LLC, Zentiva N.V. deal

BPRG will acquire 10 marketed generic products for respiratory disease from airPharma for $4 million in upfront cash and $4 million in two tranches of stock payments, the latter being contingent on certain sales milestones....
08:00 , Nov 6, 2006 |  BioCentury  |  Finance

Ebb & Flow

When New Leaf (then Sprout), Venrock and Oxford BioScience first looked into Ribozyme Pharmaceuticals in late 2002, the eponymous biotech was on the ropes. It had a market cap of just over $5 million and...
01:18 , Oct 31, 2006 |  BC Extra  |  Financial News

BioProgress raises L6.2M, acquires airPharma products

Drug delivery company BioProgress (LSE:BPRG; BPRG) raised L6.2 million ($11.7 million) in a private placement of 12.3 million shares at 50p, a 22% discount to Friday's close of 64.17p. BPRG said it will use the...
07:00 , Aug 21, 2006 |  BC Week In Review  |  Company News

BioProgress management update

BioProgress plc (LSE:BPRG; BPRG), Cambridge, U.K.   Business: Drug delivery   Hired: Hiral Patel as CFO, formerly client service director at Grant Thornton LLP; he replaces Peter Keen, who departed  ...
00:31 , Aug 16, 2006 |  BC Extra  |  Company News

Keen leaving BioProgress as CFO

Drug delivery company BioProgress (LSE:BPRG; BPRG) said CFO Peter Keen resigned by mutual agreement due to a difference in management style. BPRG hired Hiral Patel to replace Keen. Previously, Patel was a client service director...